Removal of race-adjusted antihypertensive treatment recommendations

Removal of race-adjusted antihypertensive treatment recommendations increase years with uncontrolled hypertension in silico (+0.8 years).

“Years with uncontrolled hypertension increased by 0.8 years, widening the disparity with non-Hispanic white adults from 1.7 to 2.5 years.”

In silicoNon-Hispanic Black adults; assumed heterogeneous treatment effectiveness by raceSimulated lifetime

Hypertension disease natural history and healthcare utilization when treatment guidelines do not account for race

medRxiv·7 Oct 2026Preprint

Removal of race-adjusted antihypertensive treatment recommendations decrease life expectancy in silico (-0.4 years).

“Under assumptions of heterogeneous treatment effectiveness by race, guidelines without race adjustment decreased life expectancy among non-Hispanic Black adults by 0.4 years”

In silicoNon-Hispanic Black adults; assumed heterogeneous treatment effectiveness by raceSimulated lifetime

Hypertension disease natural history and healthcare utilization when treatment guidelines do not account for race

medRxiv·7 Oct 2026Preprint